Published in Pharma Law Weekly, April 13th, 2004
As a member of the senior management team, Liberman will be responsible for managing CytRx's worldwide legal affairs, policy, and strategy. Reporting to Steven A. Kriegsman, CEO, Liberman will also serve as secretary to the company's board of directors.
"We are extremely pleased that Greg has joined CytRx," said Kriegsman. "His diversity of experience strengthens the depth of our leadership team and better positions CytRx for success."
Liberman's experience includes work as a strategic consultant and in a variety...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.